{{Rsnum
|rsid=2283873
|Gene=TCN2
|Chromosome=22
|position=30617309
|Orientation=plus
|GMAF=0.169
|Gene_s=TCN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 4.4 | 94.7
| HCB | 5.8 | 36.5 | 57.7
| JPT | 10.6 | 42.5 | 46.9
| YRI | 19.7 | 49.7 | 30.6
| ASW | 8.8 | 45.6 | 45.6
| CHB | 5.8 | 36.5 | 57.7
| CHD | 5.5 | 37.6 | 56.9
| GIH | 1.0 | 8.9 | 90.1
| LWK | 4.5 | 38.2 | 57.3
| MEX | 0.0 | 31.0 | 69.0
| MKK | 0.6 | 20.5 | 78.8
| TSI | 0.0 | 8.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22544364
|Trait=None
|Title=A genome-wide association study identifies susceptibility loci for Wilms tumor.
|RiskAllele=A
|Pval=5E-12
|OR=2.0500
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}